返回返回Regencell Bioscience Holdings Limited的營運費用(不包括COGS)。
年度數據
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
TTM
−4.74 M
−745.59 K
−18.68%
2024
−3.99 M
+1.51 M
+27.49%
2023
−5.50 M
+1.51 M
+21.52%
2022
−7.01 M
−5.66 M
−417.63%
2021
−1.35 M
−552.05 K
−68.76%
2020
−802.86 K
−411.87 K
−105.34%
半年度數據
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−3.60 M
−2.70 M
−1.80 M
−900.00 K
0.00
H2 '24
−2.42 M
−113.02 K
−4.89%
H1 '24
−2.31 M
−237.39 K
−11.44%
H2 '23
−2.07 M
+1.36 M
+39.51%
H1 '23
−3.43 M
−75.05 K
−2.24%
H2 '22
−3.35 M
+304.44 K
+8.32%